Overview

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate that the ¹³C-Octanoate Breath Test (OBT) can be used as an aid, in conjunction with other clinical information and medical history, for evaluating disease severity and detecting NASH with a high probability.
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborator:
Exalenz Bioscience LTD.